Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00201877 · COMPLETED
Trial details
- NCT number
- NCT00201877
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2009-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.